Docebo Reports First Quarter 2025 Results
TORONTO–(BUSINESS WIRE)–Docebo Inc. (NASDAQ: DCBO; TSX:DCBO) (“Docebo” or the “Company”), a leading learning platform provider with a foundation... Read more.
LEO Pharma announces Positive Topline Phase 2b Results for Temtokibart in Moderate-to-Severe Atopic Dermatitis
Temtokibart achieved positive results for the primary endpoint for the 3 highest doses in a phase 2b clinical trial in adults with moderate-to-severe atopic dermatitis... Read more.
American Strategic Investment Co. Announces First Quarter 2025 Results
Company to Host Investor Webcast and Conference Call Today at 11:00 AM ET NEW YORK–(BUSINESS WIRE)–American Strategic Investment Co. (NYSE: NYC) (“ASIC”... Read more.
Nidec Announces the Withdrawal of the Tender Offer for Makino Milling Machine Co., Ltd. (Securities Code: 6135)
KYOTO, Japan–(BUSINESS WIRE)–Nidec Corporation (TOKYO: 6594) (OTC US: NJDCY) (“Nidec” or the “Company”) announced that the Company decided to... Read more.
Sirius Therapeutics Announces Nearly $50 Million Financing to Accelerate Clinical Development of siRNA Therapeutics for Cardiometabolic Diseases
SAN DIEGO & SHANGHAI–(BUSINESS WIRE)–Sirius Therapeutics today announced that it has successfully completed nearly $50 million Series B2 financing... Read more.
Kioxia Receives IEEE Corporate Innovation Award
TOKYO–(BUSINESS WIRE)–Kioxia Corporation, a world leader in memory solutions, today announced that it has received the IEEE Corporate Innovation Award... Read more.
SiFive and Kinara Partner to Offer Bare Metal Access to RISC-V Vector Processors
Small Form Factor USB Module Offers Access to SiFive X280 SANTA CLARA, Calif.–(BUSINESS WIRE)–SiFive, Inc., the gold standard for RISC-V computing, today... Read more.
IDACORP, Inc. Prices Upsized Public Offering of 4,504,505 Shares of Common Stock
BOISE, Idaho–(BUSINESS WIRE)–IDACORP, Inc. (NYSE: IDA) announced today that it has priced an upsized underwritten public offering of 4,504,505 shares... Read more.
AriBio Co., Ltd. and Fujirebio Diagnostics, Inc. Announce Completion of Sample Set for the Strategic Partnership Implemented to Advance Biomarker Development for Alzheimer’s Disease and Neurodegeneration
SAN DIEGO & TOKYO & MALVERN, Pa.–(BUSINESS WIRE)–Fujirebio Holdings Inc., its wholly-owned subsidiary Fujirebio Diagnostics, Inc., and AriBio... Read more.
GERN Investors Have Opportunity to Join Geron Corporation Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of... Read more.